Alternate-Day Buprenorphine Administration. Phase VIII - 9



Status:Completed
Conditions:Gastrointestinal
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:25 - 48
Updated:5/7/2016
Start Date:August 1994

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Alternate-Day Buprenorphine Administration. Phase VIII

The purpose of this study is to evaluate open buprenorphine dosing with dose choice.


Please contact site for information.
We found this trial at
1
site
Treatment Research Center
Burlington, Vermont 05401
?
mi
from
Burlington, VT
Click here to add this to my saved trials